By Mill Chart
Last update: Apr 16, 2024
Let's have a look at the gap up and gap down stocks in today's session.
Ticker | Change | Comment |
---|---|---|
NCNA | 2.0K% | Exciting news for NUCANA PLC-ADR's (NASDAQ:NCNA) stock! It advanced 2.0K% to $4.55 in today's session, accompanied by a substantial gap of 2.0K%. Earlier today the company had a press release: NuCana Announces Completion of ADS Ratio Change. |
JAGX | 92.76% | In today's session, JAGUAR HEALTH INC's (NASDAQ:JAGX) stock experienced a notable rise of 92.76%, reaching $0.23 with a significant 2.03% gap. In the last month the stock gained 69.71%. |
PALI | 67.22% | PALISADE BIO INC's (NASDAQ:PALI) stock price increased by 67.22% to $6.96 with a gap of 52.91%. Shareholders saw the stock price going 23.07% lower in the past month. |
WISA | 63.63% | In today's session, WISA TECHNOLOGIES INC's (NASDAQ:WISA) stock experienced a notable rise of 63.63%, reaching $2.86 with a significant 28.17% gap. Earlier today the company had a press release: WiSA Inks Fourth HDTV/PTV License with Multi-billion Dollar Revenue Company, Signaling Rapid Adoption for its WiSA E Immersive Audio Technology. |
PRSO | 47.24% | PERASO INC's (NASDAQ:PRSO) shares surged 47.24% to $1.87 with a remarkable gap of 32.82%. The stock is trading 23.03% lower than a month ago. |
ITCI | 24.68% | During Tuesday's session, INTRA-CELLULAR THERAPIES INC's (NASDAQ:ITCI) stock price showed a remarkable increase of 24.68%, reaching $80.74 with a notable 13.99% gap. Shareholders saw the stock price going 29.36% higher is the past 6 months. |
CGEM | 16.37% | CULLINAN ONCOLOGY INC's (NASDAQ:CGEM) shares rose 16.37% to $19.26 with a gap of 9.74% during Tuesday's session. A press release (Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases) was released earlier today. |
DFLI | 15.76% | In today's session, DRAGONFLY ENERGY HOLDINGS CO's (NASDAQ:DFLI) stock experienced a notable rise of 15.76%, reaching $0.52 with a significant 6.7% gap. Yesterday the company had a press release: Dragonfly Energy Reports Fourth Quarter 2023 and Full Year Financial Results. |
AVTX | 9.71% | Exciting news for AVALO THERAPEUTICS INC's (NASDAQ:AVTX) stock! It advanced 9.71% to $16.72 in today's session, accompanied by a notable 5.16% gap. Shareholders saw the stock price going 249.0% higher in the past month. |
OPRX | 6.78% | In today's session, OPTIMIZERX CORP's (NASDAQ:OPRX) stock experienced a notable rise of 6.78%, reaching $11.02 with a significant 2.13% gap. Earlier today the company had a press release: OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results. |
To see the full list of gap up stocks you can use our gap up stocks screener.
Ticker | Change | Comment |
---|---|---|
BNED | -56.16% | Unfortunate news for BARNES & NOBLE EDUCATION INC's (NYSE:BNED) stock! It registered a 56.16% decline to $0.31 in today's session, accompanied by a 74.88% gap. A press release (Barnes & Noble Education Announces Milestone Transactions to Significantly Strengthen Balance Sheet and Advance Industry Leading Services for Institutions and Students) was released earlier today. |
CLDI | -53.97% | CALIDI BIOTHERAPEUTICS INC's (NYSEARCA:CLDI) shares fell 53.97% to $0.28 with a gap of 64.05%. Earlier today the company had a press release: Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering. |
PACB | -39.4% | Unfavorable news for PACIFIC BIOSCIENCES OF CALIF's (NASDAQ:PACB) stock! It witnessed a 39.4% decline to $1.72 in today's session, along with a 47.34% gap. The stock is trading 25.2% lower than a month ago. |
BENF | -25.44% | Unfortunate news for BENEFICIENT - CLASS A's (NASDAQ:BENF) stock! It registered a 25.44% decline to $0.07 in today's session, accompanied by a 32.49% gap. Earlier today the company had a press release: Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price. |
PRZO | -23.42% | Unfavorable news for PARAZERO TECHNOLOGIES LTD's (NASDAQ:PRZO) stock! It witnessed a 23.42% decline to $0.85 in today's session, along with a 38.43% gap. A press release (ParaZero Develops Counter Drone Solutions Leveraging Its Unique Technology) was released earlier today. |
PRFX | -23.32% | PAINREFORM LTD's (NASDAQ:PRFX) shares declined by 23.32% to $0.75, showing a 34.21% gap in today's session. The stock is trading 46.69% lower than a month ago. |
MAPSW | -22.66% | During Tuesday's session, WM TECHNOLOGY INC-CW24's (NASDAQ:MAPSW) stock price decreased by 22.66% to $0.05 with a significant 24.33% gap. Shareholders saw the stock price going 61.26% higher in the past 3 months. |
KAVL | -22.38% | In today's session, KAIVAL BRANDS INNOVATIONS GR's (NASDAQ:KAVL) stock price decreased by 22.38% to $4.89, exhibiting a 50.36% gap. In the last month the stock gained 207.0%. |
TPET | -22.14% | TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares suffered a 22.14% decline to $0.49 during Tuesday's session, accompanied by a 32.56% gap. Shareholders saw the stock price going 475.0% higher in the past month. |
OMQS | -18.29% | OMNIQ CORP's (NASDAQ:OMQS) shares fell 18.29% to $0.57 with a gap of 29.63%. The stock is trading 84.77% lower than a year ago. |
For the full top loser list go to our gap down stocks screener.
PALISADE BIO INC
NASDAQ:PALI (5/16/2024, 10:10:36 AM)
6.24
-0.14 (-2.19%)
– Company on track to commence Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year...
PALI stock results show that Palisade Bio beat analyst estimates for earnings per share the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Palisade Bio (NASDAQ:PALI) just reported results for the first quarter of 2024....
Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing, and strategic alliance...
Carlsbad, CA, May 07, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing...
Carlsbad, CA, May 02, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing...
Wednesday's session: gap up and gap down stocks
Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year end Carlsbad, CA,...
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving...
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!